维普中文期刊产品整合服务

H pylori eradication:A randomized prospective study of triple therapy with or without ecabet sodium

查看全文 作  者:Hyung Wook [1]Kim;Gwang Ha [2]Kim;Jong Yun [2]Cheong;Ung Suk [1]Yang;Seung Keun [3]Park;Chul Soo [2]Song;Dae Hwan [2]Kang;Geun Am [2]Song 高影响力作者 机构地区:[1]Department of Internal Medicine, Bongseng Memorial Hospital, Busan, Korea;[2]Department of Internal Medicine, Pusan National University School of Medicine, Busan 602-739, Korea;[3]Department of Internal Medicine, Maryknoll Hospital, Busan, Korea高影响力机构 出  处:《World Journal of Gastroenterology》索引2008年第14卷第6期,共5页高影响力期刊 基  金:An unrestricted grant by JEIL Pharm.Co.,Ltd.,Korea 摘  要:AIM: To investigate whether adding ecabet sodium to the standard triple therapy for H pylori infection improve eradication rate. METHODS: Two hundred and fifty-seven H pylori-infected patients were randomly assigned to standard triple therapy (group A, n = 129) or triple therapy plus ecabet sodium (group B, n = 128). Successful eradication was defined as a negative 13C-urea breath test 6-8 wk after completion of treatment. RESULTS: After completion of therapy, 194/257 patients showed negative 13C-urea breath test results. According to intention-to-treat analysis, the infection was eradicated in 93/129 (72.1%) patients in group A and 101/128 (78.9%) in group B (P = 0.204). Per-protocol analysis showed successful eradication in 93/118 (78.8%) patients from group A and 101/114 (88.6%) from group B (P = 0.044). There were no significant differences in the side effects experienced by the patients in the two treatment groups. CONCLUSION: Our results suggest that the addition of ecabet sodium improves the efficacy of the standard triple therapy for H pylori. 关 键 词:幽门螺杆菌 细菌感染 消化系统 疾病治疗
相关文献

参考文献(30)

引证文献(9)

耦合文献(23)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费